Insulin Detemir: all 98 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• DETERMINE: Detemir vs NPHRecruitingNCT05124457Phase 2
• The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis PatientsTerminatedNCT02496780Phase 2/3Results posted
• A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)CompletedNCT01868542Phase 4Results posted
• Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)CompletedNCT01595646Phase 2Results posted
• A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes MellitusCompletedNCT01513473Phase 3Results posted
• Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 DiabetesTerminatedNCT01486966Phase 4Results posted
• Cooperation of Insulin and GLP-1 on Myocardial Glucose UptakeCompletedNCT01232946Not applicableResults posted
• Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip TherapyCompletedNCT01186003Not applicableResults posted
• Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic DrugsCompletedNCT01068652Phase 4Results posted
• Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00909480Phase 4Results posted
• The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 DiabetesCompletedNCT00856986Phase 3Results posted
• Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin TreatmentCompletedNCT00795600Phase 4Results posted
• Transitioning Open Heart Surgery Patients From Insulin Infusions to DetemirCompletedNCT00717288Phase 4Results posted
• Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 DiabetesCompletedNCT00659165Not applicableResults posted
• Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)TerminatedNCT00639626Phase 2/3Results posted
• Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once DailyCompletedNCT00634842Phase 4Results posted
• Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689CompletedNCT00623194Phase 3Results posted
• Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.CompletedNCT00591227Phase 4Results posted
• Insulin Detemir Versus NPH Insulin In Hospitalized Patients With DiabetesCompletedNCT00590226Phase 4Results posted
• Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPHTerminatedNCT00564018Not applicableResults posted
• Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing TrialCompletedNCT00542620Phase 4Results posted
• Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 DiabetesCompletedNCT00537303Phase 4Results posted
• Effect of Insulin Detemir on Use of Energy in Type 1 DiabetesTerminatedNCT00509925Phase 4Results posted
• Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 DiabetesTerminatedNCT00506662Phase 4Results posted
• Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 DiabetesCompletedNCT00474045Phase 3Results posted
• Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in KoreaCompletedNCT00455858Phase 4Results posted
• Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 DiabetesCompletedNCT00447382Phase 3Results posted
• Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 DiabetesCompletedNCT00435019Phase 3Results posted
• Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 DiabetesCompletedNCT00184600Phase 3Results posted
• A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It WorksCompletedNCT05134987Phase 1
• Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.CompletedNCT03220425Phase 3
• Evaluation of Glycemic Changes During Exercise in Children With Type 1 DiabetesCompletedNCT02824510Not applicable
• A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human InsulinCompletedNCT02162407Phase 1
• Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 DiabetesTerminatedNCT02048189Phase 4
• Pilot Study of Glycemic Control in Diabetic Hemodialyzed PatientsCompletedNCT01828970Phase 4
• Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes MellitusCompletedNCT01709929Phase 3
• Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 DiabetesCompletedNCT01697657Phase 3
• Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 DaysCompletedNCT01547169Phase 2
• Pharmacokinetics of Insulin Detemir in Subjects With Type 1 DiabetesCompletedNCT01542450Phase 1
• Pharmacokinetics of Insulin Detemir in Healthy Chinese Male SubjectsCompletedNCT01498939Phase 1
• Comparison of Two Insulin Detemir Formulations in Healthy VolunteersCompletedNCT01498926Phase 1
• Pharmacokinetics of Insulin Detemir in Subjects With Type 2 DiabetesCompletedNCT01497600Phase 1
• Pharmacokinetics of Insulin Detemir in Healthy Volunteers From TaiwanCompletedNCT01497587Phase 1
• Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 DiabetesCompletedNCT01497574Phase 1
• Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 DiabetesCompletedNCT01497561Phase 1
• Within-subject Variability of Insulin Detemir in Healthy VolunteersCompletedNCT01497535Phase 1
• Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy SubjectsCompletedNCT01490099Phase 1
• Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 DiabetesCompletedNCT01486940Phase 3
• Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP AxisCompletedNCT01461616Phase 3
• Comparing Long-acting Insulins During Exercise in Type 1 DiabetesStatus unknownNCT01440439Phase 4
• The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 DiabetesCompletedNCT01420692Not applicable
• A Comparison of Two Initial Dosing FormulasCompletedNCT01377155Not applicable
• Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM DiagnosisStatus unknownNCT01271517Phase 4
• Insulin Detemir in Obesity ManagementActive, not recruitingNCT01239550Not applicable
• Cystic Fibrosis - Insulin Deficiency, Early ActionCompletedNCT01100892Phase 3
• Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes TreatmentCompletedNCT01076842Phase 4
• Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With MetforminCompletedNCT00941148Phase 4
• Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart InsulinWithdrawnNCT00906529Phase 4
• Examination of the Effects of Liraglutide on the Mode of Action of Insulin DetemirCompletedNCT00873223Phase 1
• Levemir-Body Composition and Energy MetabolismCompletedNCT00862875Phase 4
• A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp TrialCompletedNCT00810589Phase 1
• Detemir Energy Expenditure StudyCompletedNCT00788840Phase 4
• Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During HypoglycaemiaCompletedNCT00760448Phase 1
• Insulin Effects on Metabolism and Cardiovascular Function in Type 2 DiabetesStatus unknownNCT00747409Phase 4
• Endothelial Effects of Basal Insulin: Detemir Versus GlargineCompletedNCT00699686Phase 4
• The Copenhagen Insulin and Metformin Therapy TrialCompletedNCT00657943Phase 4
• Insulin Detemir Action in CerebroCompletedNCT00626080Not applicable
• Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With DiabetesCompletedNCT00607737Phase 4
• Safety of Insulin Detemir in Children With Type 1 DiabetesCompletedNCT00605137Phase 3
• Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00605020Phase 3
• Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesCompletedNCT00604396Phase 3
• Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring DiabetesCompletedNCT00604344Phase 3
• Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy AloneCompletedNCT00604253Phase 3
• Efficacy and Safety of Insulin Detemir in Type 1 DiabetesCompletedNCT00595374Phase 3
• Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 DiabetesCompletedNCT00592527Phase 3
• Basal Insulins - PharmacodynamicsCompletedNCT00566124Phase 4
• Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir InjectionsCompletedNCT00542399Phase 4
• Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 DiabetesCompletedNCT00522210Not applicable
• The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OADCompletedNCT00521690Phase 4
• Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 DiabetesCompletedNCT00504673Phase 3
• Hypoglycemia Counterregulation and Symptom Perception With Insulin DetemirTerminatedNCT00490893Phase 4
• Sub-Cutaneous Insulin in Hyperglycaemic EmergenciesWithdrawnNCT00467246Not applicable
• A Comparison Between Glargine and Detemir Insulin in Type 2 DiabetesCompletedNCT00457093Not applicable
• Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00383877Phase 3
• The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting InsulinsCompletedNCT00313742Phase 4
• Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 DiabetesCompletedNCT00312156Phase 3
• Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 DiabetesCompletedNCT00312104Phase 3
• Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 DiabetesCompletedNCT00283751Phase 3
• Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 DiabetesCompletedNCT00274274Phase 4
• Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 DiabetesCompletedNCT00264901Phase 4
• Comparison of Insulin Detemir With NPH Insulin in Type 1 DiabetesCompletedNCT00184665Phase 3
• Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 DiabetesCompletedNCT00184639Phase 3
• Hospital In-Patient Insulin StudyTerminatedNCT00135070Phase 4
• Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 DiabetesCompletedNCT00117780Phase 4
• Comparison of Insulin Detemir With Insulin Glargine in Type 2 DiabetesCompletedNCT00106366Phase 3
• Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 DiabetesCompletedNCT00104182Phase 3
• Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 DiabetesCompletedNCT00097084Phase 3
• Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 DiabetesCompletedNCT00095082Phase 3

← Insulin Detemir overview